SG&A expenses are up significantly, which I believe may include “$913.9 million in stock-based compensation expense, compared to $5.7 million in the year ago period, due to the vesting of certain equity awards after and as a result of the completion of our initial public offering.” If that’s a non-recurring event, then perhaps not a long term concern. But the boost in operating expenses (with investors perhaps not looking at the underlying cause) may also be affecting valuation.
Any concerns from this group?
Monitoring,
Bill